Urgent Recall Issued for Blood Pressure Medication Following Packaging Blunder
The UK Government has announced an immediate product recall for a specific batch of prescription blood pressure medication due to a critical packaging error at the manufacturing facility. This precautionary recall was initiated after it was discovered that a batch of Ramipril 5mg capsules was mistakenly packed with Amlodipine 5mg tablets instead.
Details of the Affected Batch
The recall specifically targets Ramipril 5mg Capsules with batch code GR164099. Authorities have confirmed that no other Ramipril 5mg capsules or related products are impacted by this recall. Patients who have purchased this batch are strongly advised to stop taking the medication immediately and return it to their pharmacy for a full refund.
Health Risks and Safety Information
Both Ramipril and Amlodipine are commonly prescribed to treat high blood pressure, but they function differently within the body. Taking Amlodipine when Ramipril is expected could lead to a sudden drop in blood pressure, potentially causing dizziness or other adverse effects. However, health officials have emphasized that the risk to individuals who may have already taken the incorrect tablets is very low.
Patients are urged to check the outer packaging of their Ramipril 5mg capsules for the batch code GR164099. If this code is present, they should discontinue use and consult their pharmacy or healthcare provider for further guidance.
Official Statements and Contact Information
Crescent Pharma Limited, the manufacturer of the medication, issued the recall in collaboration with pharmacies across the UK. Tesco, one of the retailers affected, released a statement apologizing for any inconvenience caused and assuring customers of their commitment to safety.
For additional assistance, patients can email medinfo@crescentpharma.com or report adverse reactions to safety@crescentpharma.com or by calling 01217 901596. Further details are available on the government website under the notice: Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 5mg capsules, EL(26)A/11.
This incident highlights the importance of stringent quality control in pharmaceutical manufacturing to prevent such errors and ensure patient safety.
